Skip Navigation

Cole Meagher

Select Experience

A representative list of Cole's cases of public record includes acting for:

  • Janssen and the Kennedy Trust in a patent impeachment and infringement action relating to Remicade (infliximab), a biologic treatment for rheumatoid arthritis

  • CCM Hockey in successfully defending a patent infringement action resulting in a $2.5-million cost award

  • The Canadian Organization for Rare Diseases as an intervenor challenging the 2019 amendments to the Patented Medicines Regulations

  • An innovator pharmaceutical manufacturer in a claim under the Statute of Monopolies and section 8 of the Patented Medicines (Notice of Compliance) Regulations

  • An innovator pharmaceutical manufacturer in patent infringement actions related to its multiple sclerosis treatment

  • Shire (now Takeda) in a patent impeachment proceeding relating to Vyvanse (lisdexamfetamine)

Awards & Recognition

Cole is recognized in the following publication:

  • Best Lawyers: Ones to Watch in Canada – 2022–2024 (Intellectual Property Law)
Professional Activities

Cole is a member of the Ontario and Canadian Bar Associations, The Advocates' Society and the Intellectual Property Institute of Canada (IPIC).

Education
JD, Queen's University – 2017
HBSc (Life Sciences), Queen's University – 2014
More insights

Save Profile

Select sections to customize your PDF

Share this page